Published in Medical Devices and Surgical Technology Week, August 31st, 2003
The company reported a loss of $0.36 per share for the period compared with a loss of $0.55 per share for the second quarter of 2002. The second quarter results include noncash charges of $0.5 million and $1.6 million, respectively, for stock-based compensation expense and asset impairment charges, and $0.5 million in restructuring charges.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week